Specific inhibitors of Pseudomonas aeruginosa elastase as potential drugs for the treatment of Pseudomonas keratitis.
D000818:Animals; D001426:Bacterial Proteins; D004151:Dipeptides / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity; D006020:Glycopeptides / Q000627:therapeutic use; D007634:Keratitis / Q000188:drug therapy*; D007930:Leucine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008666:Metalloendopeptidases; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000201:enzymology*; D011817:Rabbits; D015842:Serine Proteinase Inhibitors
D001426:Bacterial Proteins; D004151:Dipeptides; D006020:Glycopeptides; D015842:Serine Proteinase Inhibitors; C038770:benzyloxycarbonylleucyl-hydroxamate; C033601:phosphorylleucylphenylalanine; C038771:2-mercaptoacetyl-phenylalanylleucine; D008666:Metalloendopeptidases; C043859:pseudolysin, Pseudomonas aeruginosa; D007930:Leucine; C008890:phosphoramidon